Pharmaceuticals & Biotech Community

Our community narratives are driven by numbers and valuation.

AFT Pharmaceuticals

RO

Robbo

Community Contributor

Expansion or Overextension? The Risks Behind AFT’s Global Push.

AFT Pharmaceuticals is a New Zealand-based pharmaceutical business with global ambitions. The company has publicly set a goal of achieving NZ$300 million in revenue by the end of 2027—a target repeated in its 2025 annual report, market release, shareholder letter, and chairman’s address.

NZ$2.8

FV

0.7% overvalued

7.05%

Revenue growth p.a.

0

0

1

New